Jacobs & Co
- SEC CIK
- 0001055544
- Latest filing
- Jul 8, 2026
GILD holding history
Gilead Sciences, Inc. in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GILD overviewAll 13F holders of GILDFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,090
- Value
- $516.0K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,090 | $516.0K | <0.1% | −139−3.3% | Reduced | Holders |
| Q1 2026 | 4,229 | $589.0K | 0.1% | −33−0.8% | Reduced | Holders |
| Q4 2025 | 4,262 | $523.0K | <0.1% | −288−6.3% | Reduced | Holders |
| Q3 2025 | 4,550 | $505.0K | <0.1% | −25−0.5% | Reduced | Holders |
| Q2 2025 | 4,575 | $507.0K | 0.1% | −315−6.4% | Reduced | Holders |
| Q1 2025 | 4,890 | $547.0K | 0.1% | −275−5.3% | Reduced | Holders |
| Q4 2024 | 5,165 | $477.0K | <0.1% | −580−10.1% | Reduced | Holders |
| Q3 2024 | 5,745 | $481.0K | <0.1% | −4,877−45.9% | Reduced | Holders |
| Q2 2024 | 10,622 | $728.0K | 0.1% | −16,640−61.0% | Reduced | Holders |
| Q1 2024 | 27,262 | $2.00M | 0.2% | +725+2.7% | Added | Holders |
| Q4 2023 | 26,537 | $2.15M | 0.2% | −784−2.9% | Reduced | Holders |
| Q3 2023 | 27,321 | $2.05M | 0.3% | +35+0.1% | Added | Holders |
| Q2 2023 | 27,286 | $2.10M | 0.2% | +105+0.4% | Added | Holders |
| Q1 2023 | 27,181 | $2.25M | 0.3% | +195+0.7% | Added | Holders |
| Q4 2022 | 26,986 | $2.32M | 0.3% | +127+0.5% | Added | Holders |
| Q3 2022 | 26,859 | $1.66M | 0.2% | +560+2.1% | Added | Holders |
| Q2 2022 | 26,299 | $1.63M | 0.2% | +775+3.0% | Added | Holders |
| Q1 2022 | 25,524 | $1.52M | 0.2% | +1,835+7.7% | Added | Holders |
| Q4 2021 | 23,689 | $1.72M | 0.2% | −4,400−15.7% | Reduced | Holders |
| Q3 2021 | 28,089 | $1.96M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 28,089 | $1.93M | 0.2% | +525+1.9% | Added | Holders |
| Q1 2021 | 27,564 | $1.78M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.